Park Avenue Securities’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.22M | Sell |
53,905
-49,311
| -48% | -$3.98M | 0.03% | 425 |
|
|
2026
Q1 | $8.94M | Buy |
+103,216
| New | +$9.89M | 0.07% | 217 |
|
|
2025
Q4 | – | Sell |
-47,057
| Closed | -$4.48M | – | 1633 |
|
|
2025
Q3 | $4.48M | Buy |
47,057
+3,830
| +9% | +$352K | 0.04% | 347 |
|
|
2025
Q2 | $3.77M | Sell |
43,227
-6,329
| -13% | -$537K | 0.03% | 334 |
|
|
2025
Q1 | $4.45M | Buy |
49,556
+10,462
| +27% | +$936K | 0.05% | 220 |
|
|
2024
Q4 | $3.12M | Buy |
39,094
+14,101
| +56% | +$1.22M | 0.03% | 336 |
|
|
2024
Q3 | $2.25M | Buy |
24,993
+809
| +3% | +$68.1K | 0.03% | 401 |
|
|
2024
Q2 | $1.9M | Sell |
24,184
-22,580
| -48% | -$1.85M | 0.02% | 431 |
|
|
2024
Q1 | $4.08M | Buy |
46,764
+7,841
| +20% | +$669K | 0.05% | 234 |
|
|
2023
Q4 | $3.21M | Sell |
38,923
-24,954
| -39% | -$1.9M | 0.04% | 251 |
|
|
2023
Q3 | $5M | Buy |
63,877
+2,793
| +5% | +$234K | 0.08% | 159 |
|
|
2023
Q2 | $5.38M | Buy |
61,084
+10,272
| +20% | +$884K | 0.09% | 157 |
|
|
2023
Q1 | $4.1M | Buy |
50,812
+4,162
| +9% | +$339K | 0.07% | 175 |
|
|
2022
Q4 | $3.63M | Buy |
46,650
+2,830
| +6% | +$229K | 0.06% | 190 |
|
|
2022
Q3 | $3.54M | Buy |
43,820
+2,486
| +6% | +$223K | 0.07% | 169 |
|
|
2022
Q2 | $3.71M | Buy |
41,334
+5,247
| +15% | +$532K | 0.07% | 168 |
|
|
2022
Q1 | $4M | Buy |
36,087
+3,863
| +12% | +$408K | 0.07% | 155 |
|
|
2021
Q4 | $3.33M | Buy |
32,224
+909
| +3% | +$105K | 0.06% | 187 |
|
|
2021
Q3 | $3.92M | Buy |
31,315
+2,225
| +8% | +$288K | 0.08% | 130 |
|
|
2021
Q2 | $3.61M | Sell |
29,090
-423
| -1% | -$53.1K | 0.08% | 132 |
|
|
2021
Q1 | $3.49M | Buy |
29,513
+3,355
| +13% | +$393K | 0.08% | 120 |
|
|
2020
Q4 | $3.06M | Buy |
26,158
+1,613
| +7% | +$178K | 0.09% | 108 |
|
|
2020
Q3 | $2.55M | Buy |
24,545
+2,161
| +10% | +$217K | 0.09% | 108 |
|
|
2020
Q2 | $2.05M | Buy |
22,384
+2,409
| +12% | +$231K | 0.08% | 112 |
|
|
2020
Q1 | $1.8M | Buy |
19,975
+2,830
| +17% | +$301K | 0.15% | 59 |
|
|
2019
Q4 | $1.95M | Buy |
17,145
+1,535
| +10% | +$168K | 0.08% | 105 |
|
|
2019
Q3 | $1.7M | Sell |
15,610
-1,379
| -8% | -$144K | 0.08% | 100 |
|
|
2019
Q2 | $1.66M | Buy |
16,989
+4,191
| +33% | +$383K | 0.19% | 46 |
|
|
2019
Q1 | $1.16M | Buy |
12,798
+3,595
| +39% | +$322K | 0.06% | 112 |
|
|
2018
Q4 | $781K | Buy |
9,203
+1,421
| +18% | +$133K | 0.12% | 61 |
|
|
2018
Q3 | $774K | Buy |
7,782
+1,346
| +21% | +$124K | 0.12% | 59 |
|
|
2018
Q2 | $554K | Sell |
6,436
-1,398
| -18% | -$117K | 0.1% | 71 |
|
|
2018
Q1 | $607K | Buy |
7,834
+3,789
| +94% | +$313K | 0.13% | 50 |
|
|
2017
Q4 | $333K | Buy |
4,045
+488
| +14% | +$39.1K | 0.09% | 75 |
|
|
2017
Q3 | $278K | Sell |
3,557
-474
| -12% | -$39.4K | 0.09% | 68 |
|
|
2017
Q2 | $375K | Buy |
+4,031
| New | +$340K | 0.04% | 99 |
|
|
2017
Q1 | – | Sell |
-3,326
| Closed | -$235K | – | 63 |
|
|
2016
Q4 | $235K | Buy |
3,326
+298
| +10% | +$23.4K | 0.12% | 43 |
|
|
2016
Q3 | $262K | Buy |
3,028
+262
| +9% | +$22.8K | 0.15% | 31 |
|
|
2016
Q2 | $241K | Buy |
+2,766
| New | +$224K | 0.04% | 73 |
|
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
VF
Park Avenue Securities's MDT Position: Q2 2026 in Review
Park Avenue Securities reduced its Medtronic (MDT) stake by 48% in Q2 2026, selling an estimated $3.98M and leaving 53,905 shares worth $4.22M. The position accounts for 0.03% of the portfolio, ranked #425.
Park Avenue Securities first reported a position in MDT in Q2 2016 and has held it in 39 quarters since. The position peaked at $8.94M in Q1 2026. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Park Avenue Securities held 53,905 shares of Medtronic worth $4.22M as of Q2 2026.
- Park Avenue Securities sold 49,311 Medtronic shares in Q2 2026, an estimated $3.98M.
- Medtronic made up 0.03% of Park Avenue Securities's portfolio in Q2 2026, its #425 holding.
- Park Avenue Securities first reported a position in Medtronic in Q2 2016 and has held it in 39 quarters since.
- Park Avenue Securities's Medtronic position peaked at $8.94M in Q1 2026.
- 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.